Alfa Wassermann has named Mark Flocco and Dino DiCamillo as vice president and president, respectively, to its proteomic technologies division, Alfa Wassermann Proteomic Technologies.

DiCamillo comes to Alfa Wassermann from Invitrogen, where he was vice president of environmental diagnostics and commercial operations. Prior to that, he was president of Dynal Biotech, spent 13 years with Applied Biosystems, and has worked for Nicolet Instruments and Bio-Rad Laboratories.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.